Jason Kolbert

Stock Analyst at D. Boral Capital

(0)
# 4199
Out of 5,240 analysts
232
Total ratings
28.86%
Success rate
-7.75%
Average return
70 Stocks
Name Action Price Target Current % Upside Ratings Updated
Context Therapeutics
Maintains: Buy
9 9
1 800% 2 Jan 15, 2025
Artelo Biosciences
Maintains: Buy
6 6
1.14 426.32% 3 Jan 14, 2025
Anixa Biosciences
Maintains: Buy
10 10
2.15 365.12% 7 Jan 14, 2025
Biomea Fusion
Maintains: Buy
128 16
4.16 284.62% 9 Jan 13, 2025
Humacyte
Maintains: Buy
25 25
4.11 508.27% 7 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
46 46
10.46 339.77% 7 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 12
0.45 2566.67% 7 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 10
1.04 861.54% 9 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
11.22 33.69% 1 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
3.14 186.62% 1 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
0.4 2150% 4 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 5
0.66 657.58% 4 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 32
1.99 1508.04% 2 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 21
3.94 432.99% 9 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 25
8.89 181.21% 2 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 17
1.01 1583.17% 5 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 5
1.58 216.46% 4 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
3.5 157.14% 8 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 31
5.08 510.24% 6 Jan 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 30
2.33 1187.55% 6 Jan 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
7.47 207.9% 1 Jan 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
2 2
0.55 263.64% 3 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 12
1.7 605.88% 4 Jan 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 10
1.59 528.93% 6 Dec 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 16
1.89 746.56% 6 Dec 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
8.59 319.09% 1 Dec 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23 23
4.84 375.21% 7 Dec 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 29
0.88 3195.45% 6 Dec 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 15
5.77 159.97% 2 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 18
2.1 757.14% 8 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 13
1.13 1050.44% 6 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 25
9.91 152.27% 6 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
1.9 373.68% 2 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 14
3.84 264.58% 3 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 15
1.57 855.41% 3 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
1.57 473.25% 2 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
0.54 455.56% 5 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 21
4.66 350.64% 4 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 21
n/a n/a 3 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
n/a n/a 1 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 6
1.06 466.04% 1 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
96
0.23 41639.13% 1 Feb 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jul 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16002 45990
2.99 1538027.09% 1 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
0.72 16566.67% 1 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.13 4515.38% 1 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Sep 16, 2022